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Abstract
Background: MiR arrays distinguish themselves from gene expression arrays by their more limited number of
probes, and the shorter and less flexible sequence in probe design. Robust data processing and analysis methods
tailored to the unique characteristics of miR arrays are greatly needed. Assumptions underlying commonly used
normalization methods for gene expression microarrays containing tens of thousands or more probes may not
hold for miR microarrays. Findings from previous studies have sometimes been inconclusive or contradictory.
Further studies to determine optimal normalization methods for miR microarrays are needed.
Methods: We evaluated many different normalization methods for data generated with a custom-made two
channel miR microarray using two data sets that have technical replicates from several different cell lines. The
impact of each normalization method was examined on both within miR error variance (between replicate arrays)
and between miR variance to determine which normalization methods minimized differences between replicate
samples while preserving differences between biologically distinct miRs.
Results: Lowess normalization generally did not perform as well as the other methods, and quantile normalization
based on an invariant set showed the best performance in many cases unless restricted to a very small invariant
set. Global median and global mean methods performed reasonably well in both data sets and have the
advantage of computational simplicity.
Conclusions: Researchers need to consider carefully which assumptions underlying the different normalization
methods appear most reasonable for their experimental setting and possibly consider more than one
normalization approach to determine the sensitivity of their results to normalization method used.
Background
MicroRNAs (miRs) are a class of short, highly conserved
non-coding RNAs known to play important roles in
numerous developmental processes. MiRs regulate gene
expression through incomplete base-pairing to a com-
plementary sequence in the 3′ untranslated region (3′
UTR) of a target mRNA, resulting in translational
repression and, to a lesser extent, accelerated turnover
o ft h et a r g e tt r a n s c r i p t[ 1 ] .R ecently, the dysregulation
of miRs has been linked to cancer initiation and pro-
gression [2], indicating that miRs may play roles as
tumor suppressor genes or oncogenes [3]. There is also
mounting evidence that miRs are important in develop-
ment timing [4,5], cell differentiation [6], cell cycle con-
trol and apoptosis [7]. The involvement of miRs in
those biological functions suggests their intrinsic roles
in maintaining homeostasis or contributing to pathologi-
cal processes.
Technologies utilized for relative quantification of miR
expression include Northern blot, real time PCR, in situ
hybridization, sequence analysis and array-based profil-
ing [8]. Due to the limited throughput of other technol-
ogies, microarray-based miR profiling has become a
popular method for interrogation of miRs, especially
when the contributions of specific miRs to a given con-
dition or process remain elusive. However, miR arrays
distinguish themselves from gene expression arrays by
their more limited number of probes, and the shorter
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processing and analysis methods tailored to the unique
characteristics of miR arrays are greatly needed.
Normalization is a key early step in miR microarray
data processing. Normalization methods are aimed at
removing data artifacts resulting from systematic or ran-
dom technical variation. If not removed, these artifacts
might affect subsequent data analyses, such as class
comparison and class prediction. Assumptions underly-
ing commonly used normalization methods for gene
expression microarrays containing tens of thousands or
more probes may not hold for miR microarrays. Further
studies to determine optimal normalization methods for
miR microarrays are needed. The best normalization
method may differ depending on whether the miR chip
uses a one-channel or two-channel system. In a one
channel system, single samples are labeled and hybri-
dized to individual arrays. For arrays using a two-chan-
nel system, generally two samples are separately labeled,
mixed, and hybridized together to each array. The most
commonly used design for a two-channel system is
called the reference design. One of the samples is used
as an internal standard so that the signal intensity which
reflects the amount of hybridization to a probe for a
sample of interest is measured relative to the intensity
for the same probe on the same array for the reference
sample [9].
Several papers comparing miR microarray normaliza-
tion methods have been published; however, the results
and recommendations are not consistent. Rao et al [10]
compared normalization methods for single channel
miR microarray data. They reported that quantile nor-
malization was the best performing method for reducing
the differences in microRNA expression values among
replicate tissue samples. Pradervand et al. [11] con-
firmed that quantile normalization was the most robust
normalization method for their set of invariant miRs
using the Agilent single channel platform. In contrast,
Hua et al. [12], using Rt-PCR as a gold standard, found
that the lowess method gave the best result for two-
channel miR microarray data, although the differences
among their top performing methods were minimal.
However, the suitability of Rt-PCR as a comparator for
miR microarray expression results has been questioned
[8,13], and the stability of lowess smoothers is known to
be dependent on the number of data points to which
they are applied. Sarkar et al. [14] reported quality
assessment for two- channel miR expression arrays, and
they found that all normalization methods performed
adequately in their study.
Here we report our evaluation of many different nor-
malization methods on a custom-made two channel
miR microarray. Our study examined technical repli-
cates from a large number of different cell lines to
determine which normalization methods minimized
differences between replicate samples while preserving
differences between biologically distinct miRs.
Methods
Cell line culture
Ten lung carcinoma cell lines from the NCI60 panel
were obtained from the National Cancer Institute’s
Developmental Therapeutics Program (DTP), and 9
renal cell carcinoma cell lines were generated at the
Surgery Branch, National Cancer Institute, National
Institutes of Health (NIH). All cell lines were cultured
in complete RPMI media supplemented with 10% FBS,
1 mM HEPES, 1 mM Ciprofloxacin and L-glutamine/
penicillin/streptomycin. All cells were cultured at 37°C
under 5% CO2. Cells were harvested at sub-confluent
condition by trypsin-versene (Invitrogen) detachment
and centrifugation after 3-5 days in culture. A single
EBV cell line used as the reference sample was cultured
in the same media in suspensional growth cells and har-
vested by centrifugation at 1200 rpm for 5 min after
one week of culture. Cell pellets were immediately lysed
in Trizol at 1-2e7 cell per ml of Trizol.
RNA isolation and labeling
Total RNA from 10 lung carcinoma cell lines and 9
renal cell carcinoma cell lines were isolated using Trizol
reagent. Small RNA in total RNA samples were enriched
and purified by flashPAGE Fractionator (Ambion, Aus-
tin, TX USA) according to the manufacturer’si n s t r u c -
tion. The reference sample consisting of one EBV cell
line was processed following identical procedures. After
small RNA purification, small RNA from test samples
and EBV reference samples, equivalent to 10 μgo ft h e
total RNA, were labeled with Cy5 and Cy3, respectively,
using mirVana™ miRNA Labeling Kit (Ambion, Austin,
TX USA).
Microarray fabrication and quality control procedures
A custom-made oligo array including 714 human, mam-
malian and viral mature antisense miRs (mirbase: http://
microrna.sanger.ac.uk/, version9.1) plus 2 internal con-
trols with 7 serial dilutions [2,6,15] were printed at
Infectious Disease and Immunogenetics Section, Depart-
ment of Transfusion Medicine, Clinical Center, NIH.
T h ea n t i s e n s em i Ro l i g op r o b e sw e r e5 ′ amine modified
and immobilized in duplicate (two spots per miR per
array) on CodeLink activated slides (GE Health, NJ,
USA) via covalent binding. Serially diluted control
probes were used as indicators of labeling efficiency,
optimization of intensity saturation, and intensity bal-
ance of test vs. reference sample. A single large labeling
reaction of the EBV reference samples was used for all
arrays. Strong and positive EBV-miR hybridization also
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the reference sample.
Sample hybridization and image analysis
Equal amounts of labeled test and reference samples
were cohybridized on the custom made miR oligo
microarray for more than 14 hours at room tempera-
ture. After washing, the array was scanned using a Gen-
ePix 4B scanner. Any spot smaller than 25 pixels was
filtered out and excluded from remaining analyses. If
both channels produced intensities less than 100 for a
given microRNA, that spot was also filtered out. For
spots with one channel intensity less than 100 but the
other channel intensity 100 or greater, the signal less
than 100 was set to 100 prior to calculation of the signal
ratio. The intensity ratio for each spot was then calcu-
lated as the red signal intensity (test samples) divided by
the green channel signal intensity (EBV reference sam-
ples). Both single channel intensities and intensity ratios
were log transformed (base 2) for normalization and
further analyses. Overall, 9 out of 10 lung carcinoma
cell lines and all 9 renal cell carcinoma cell lines have
duplicate samples while one lung carcinoma cell lines
has quadruplicate samples.
Normalization Methods
1) Median
This normalization method uses the global median
of log intensity ratios on each chip as the normaliza-
tion factor. The global median log intensity ratio is
calculated across all spots on the chip, and then this
value is subtracted from the log intensity ratio for
each spot. The global median of the normalized log
intensity ratios equals zero.
2) Mean
This normalization method uses the global mean of
log intensity ratios on each chip as the normalization
factor. The global mean log intensity ratio is calcu-
lated across all spots on the chip, and then this
value is subtracted from the log intensity ratio for
each spot. The global mean of the normalized log
intensity ratios equals zero.
3) Trimmed Mean
This normalization method is similar to the mean
normalization method except that a trimmed mean
of log intensity ratios on each chip is used as the
normalization factor in place of the overall mean. A
trimmed mean is calculated by discarding a certain
percentage of the lowest and the highest log inten-
sity ratios and then computing the mean of the
remaining log intensity values. It is less susceptible
to the effects of extreme values. In our experiments,
we used a trimming percentage of 1% from both the
lowest and highest data values.
4) Lowess
Lowess normalization assumes that the dye bias
might be dependent on spot intensity. Let (logG,
logR) be the green and red background-corrected log
intensities. Then, (M, A)a r ed e f i n e db yM = log(R/
G)a n d AR G = 1
2
log( ). Note that M is the unnor-
malized log ratio.
The adjusted log ratio for the jth miR is computed
by: Mj*(Aj)=M j -c ( A j), where c(Aj)i st h el o w e s s
curve fit to the MA plot. For the calculations pre-
sented in this paper, the lowess curve was calculated
using the R function loess with a span set at 0.5 [16].
5) Quantile-quantile
Quantile normalization [17] assumes that the distri-
bution of miR abundances is nearly the same in all
samples. For convenience, an artificial reference chip
is created by pooling intensities across all chips in
the experiment to produce an intensity reference
distribution. This reference distribution is described
by a distribution function F2.T on o r m a l i z ee a c h
chip, the distribution of miR intensities for that chip
(e.g. denoted by the distribution function F1)i s
transformed to equal the reference intensity distribu-
tion. Operationally, this transformation is accom-
plished by determining for each signal intensity on
the chip its quantile in the chip’s intensity distribu-
tion and replacing that value with the value having
that quantile in the reference distribution. In a for-
mula, the transform is
xnorm =F 2
-1(F1(x)),
where F1 is the distribution function of the actual
chip, and F2 is the distribution function of the refer-
ence chip.
6) Invariant set option
Sometimes the normalization factors or curves cal-
culated as described above are derived using only an
i n v a r i a n ts u b s e to ft h ep r o b e s( e . g . ,m i R s ) .T h e
notion of invariant set normalization was first intro-
duced for Affymetrix gene expression chips [18], but
it can be generalized to miR arrays. This method
assumes that there is a set of reference miRs that
are invariant across a set of samples. Rather than
requiring ap r i o r ispecification of a standard set of
“housekeeping miRs”, the invariant set is determined
empirically. The invariant probes are identified by
determining those probes which have most similar
rank order across all arrays as measured by the
smallest variance of ranks. There is some arbitrari-
ness in deciding what percentage of the probes
belong in the invariant set, so in our study we con-
sidered several possible percentages, including 10%,
20%, 30% and 40% of the probes with the smallest
variance to serve as the “invariant set”.N o r m a l i z a -
t i o nm e t h o d s1 )t o5 )w e r et h e nr e a p p l i e db a s e do n
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of miRs including 40% of the probes with smallest
variance was used only for the quantile normaliza-
tion method.
The shorthand notation used to indicate the various
normalization methods is the name of the main
approach (Median, Mean, trimmed Mean, Lowess,
or Quantile) with a suffix indicating the size of the
invariant set used, if any (.10,.20,.30,.40). No suffix
indicates that the full set of miRs was used.
Measures of variation
We examined the impact of each normalization method
on both within miR error variance (between replicate
arrays) and between miR variance. This analysis was
based on a components of variance model:
Ym e ij i ij =+
where Yij denotes the log transformed intensity ratio
of ith miR in the jth replicate. The error variance com-
ponent σ e
2 associated with eij (technical error) repre-
sents the reproducibility of the method. The variance
component σ m
2 associated with mi (true miR expression)
represents the true miR-to-miR variability. Formulas for
computing the variance components and intra-class cor-
relation based on method-of-moments estimation for
each cell line under each normalization method can be
computed as in Korn et al. [19]. The error variance
(within-miR) variance component is estimated by

∧
=− −
= = ∑ ∑ e ij i m a
j
n
i
n
YY n n
a m 2
2
1 1
1 () / [ ( ) ] .
where na = number of replicate arrays, nm =n u m b e r
of miRs and
YY n ii j a
j
na
. / =
= ∑
1
The between-miR variance component is estimated by
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The estimated intra-class correlation (ICC)f o re a c h
cell line is
ICC mm e =+
∧∧ ∧

22 2
/( )
and it estimates the proportion of the total variance
(sum of within and between miR variances) due to the
between miR variance. It is desirable for the ICC to be
large (close to one), indicating that the technical error
variance is relatively small compared to biological differ-
ences between miRs [19]. When the error variance is
fairly high, it is possible for the estimated ICC to be
negative due to use of method-of-moments estimation,
especially when the number of technical replicates is
small. The advantage of the method-of-moments esti-
mators is that they are unbiased and simple to compute.
Statistical tests for differences in ICC between
normalization methods
We examined the following normalization methods: no
normalization, mean, median, trimmed mean, lowess
and quantile normalization based on all miRs (N = 6
normalization methods); based on the three invariant
sets defined above for the mean, median, trimmed
mean, and lowess methods (N = 12); and based on four
invariant sets for the quantile method (N = 4). For each
of these normalization methods, there were 19 ICC
values computed, corresponding to 10 lung cancer cell
lines and 9 renal cancer cell lines. Separately for the
lung cancer cell lines and the renal cancer cell lines,
Wilcoxon signed-rank tests were applied to the ICC for
each of the 231 possible pairings of these methods. Two
methods were considered statistically significantly differ-
ent if the 2-sided p-value from the signed-rank test was
less than a =0 . 0 1 .T h i sa level was chosen so that the
expected number of false positive differences would be
no more than 3 among the 231 paired tests for each of
the two cell line experiments.
Results
The ICCs for different normalization methods using the
ten lung cancer cell lines ranged from -0.30 to 0.87 (see
T a b l e1 ,2a n dF i g u r e1 ) .T h eq u a n t i l en o r m a l i z a t i o n
methods based on invariant sets were observed to pro-
duce the highest mean ICCs across the ten lung cancer
cell lines (mean ICC > 0.60, for all invariant set sizes
10-40%). The worst performing methods were the low-
ess methods when based on invariant sets (mean ICC <
0.50). For all pairwise comparisons of invariant set
quantile normalization versus invariant set lowess nor-
malization, the distribution of ICCs was significantly
lower for the lowess-based methods compared to the
quantile-based methods (P < 0.01 for all pairs, Wilcoxon
signed rank tests). Cell line effects were also apparent,
with the lowest average ICC observed for cell line 1
Zhao et al. Journal of Translational Medicine 2010, 8:69
http://www.translational-medicine.com/content/8/1/69
Page 4 of 7(mean ICC = 0.02, empty blue circle in Figure 1) and
the highest average ICC observed for cell line 3 (mean
ICC = 0.84, empty green square in Figure 1). When
using the full data set (not restricting to an invariant
set), global mean, global trimmed-mean, and global
median performed about equally well, although those
ICCs were somewhat lower than the ICCsf o rt h eq u a n -
tile-based methods using invariant sets. With the excep-
tion of the lowess methods and methods using small
invariant sets (e.g., 10%), performing some type of nor-
malization generally produced higher ICCst h a np e r -
forming no normalization.
The ICCs for different normalization methods for the
experiment involving nine renal cancer cell lines ranged
from 0.66 to 0.96 (see Table 3, 4 and Figure 2). Overall,
the ICCs were higher for the renal cell lines than for the
lung cancer cell lines, likely due to the more controlled
setting in which the renal cancer cell lines were pro-
cessed, although it is possible that biological differences
between the lung and renal cell lines could also partly
explain the findings. The entire set of renal cancer cell
line experiments was performed in one flash page batch
by one technician, in contrast to the lung cancer cell
line experiments, which were processed in several
batches. When using the full set of miRs for normaliza-
tion, the mean, trimmed mean, and median normaliza-
tion methods all produced similarly high ICCs. As was
observed for the lung cancer cell line experiments, the
lowess methods based on invariant sets tended to pro-
duce lower ICCs and the quantile methods based on
invariant sets tended to produce higher ICCs. Compar-
ing invariant set quantile normalization to invariant set
lowess normalization, ICCs were always observed to be
lower for the lowess-based methods compared to the
quantile-based methods with the pairwise differences
reaching statistical significance for most pairs (P < 0.01
for most pairs, Wilcoxon signed rank tests) [Additional
Table 1 Summary statistics for performance of different
normalization methods based on intra-class correlations
(ICCs) computed for replicate miR microarray data
obtained using 10 different lung cancer cell lines
Methods Min Max Median Mean SD
No.Norm -0.03 0.82 0.55 0.51 0.25
Mean -0.02 0.87 0.58 0.56 0.27
t.Mean -0.02 0.87 0.58 0.56 0.27
Median -0.06 0.87 0.56 0.54 0.27
Lowess 0.05 0.87 0.51 0.53 0.26
Quantile 0.17 0.78 0.54 0.52 0.18
Mean.10 -0.15 0.84 0.38 0.36 0.36
Mean.20 -0.05 0.86 0.55 0.54 0.28
Mean.30 -0.03 0.87 0.56 0.55 0.27
t.Mean.10 -0.15 0.84 0.38 0.36 0.36
t.Mean.20 -0.05 0.86 0.55 0.53 0.28
t.Mean.30 -0.02 0.87 0.56 0.55 0.27
Median.10 -0.21 0.86 0.36 0.35 0.39
Median.20 -0.11 0.87 0.56 0.54 0.29
Median.30 -0.07 0.87 0.57 0.55 0.28
Lowess.10 -0.30 0.73 0.16 0.23 0.35
Lowess.20 -0.06 0.85 0.37 0.42 0.30
Lowess.30 0.02 0.87 0.44 0.48 0.28
Quantile.10 0.24 0.86 0.62 0.60 0.20
Quantile.20 0.39 0.87 0.67 0.65 0.16
Quantile.30 0.38 0.85 0.63 0.62 0.18
Quantile.40 0.34 0.86 0.65 0.62 0.18
Table 2 Summary statistics for 10 different lung cancer
cell lines based on intra-class correlations (ICCs)
computed for replicate miR microarray data processed
using different normalization methods
Cell lines Min Max Median Mean SD
1 -0.21 0.39 -0.03 0.02 0.17
2 -0.30 0.59 0.33 0.26 0.24
3 0.72 0.87 0.85 0.84 0.04
4 0.13 0.50 0.40 0.39 0.07
5 0.18 0.64 0.59 0.53 0.13
6 -0.05 0.71 0.53 0.46 0.19
7 0.47 0.77 0.67 0.66 0.07
8 -0.01 0.55 0.46 0.38 0.18
9 0.60 0.76 0.74 0.73 0.05
10 0.60 0.87 0.85 0.82 0.07
Figure 1 D o tp l o tf o rc o m p a r i s o no fICCso b s e r v e df o r
different normalization methods applied to replicate miR
microarray data from 10 lung cancer cell lines. The y axis is the
intra-class correlation coefficient (ICC), and the x-axis lists different
normalization methods. The x-axis indicates the normalization
method used. The shorthand notation for the normalization method
is the name of the main approach (Median, Mean, trimmed Mean,
Lowess, or Quantile) with a suffix indicating the size of the invariant
set used, if any (.10,.20,.30,.40). No suffix indicates that the full set of
miRs was used.
Zhao et al. Journal of Translational Medicine 2010, 8:69
http://www.translational-medicine.com/content/8/1/69
Page 5 of 7file 1, 2]. With the exception of the lowess method
based on 10% invariant set, performing some type of
normalization produced a higher ICC than performing
no normalization at all.
Discussion
Data normalization is an important step in the analysis
of microarray data. We explored a comprehensive col-
lection of normalization methods in miR microarray
experiments using lung cancer cell lines and renal
cancer cell lines to address the question of which nor-
malization methods might be most appropriate for miR
microarray data. We tested global mean, trimmed mean,
global median, lowess, and quantile-quantile methods
and examined the impact of using each of these meth-
ods restricted to an empirically determined invariant
miR set. We found that for our data sets, lowess nor-
malization generally did not perform as well as the
other methods. For the lung cancer cell lines quantile
normalization applied to an invariant set was best on
average unless restricted to a very small invariant set
(e.g., 10%). Quantile normalization with invariant set
also performed well for the renal cancer cell lines, but
average observed ICCs were slightly higher for global
median and mean methods. The good performance of
quantile normalization restricted to an invariant miR set
observed in our study is consistent with a previous
study reported for a one channel miR chip [11]. Global
median and global mean methods performed reasonably
well in both data sets and have the advantage of compu-
tational simplicity.
Although many different normalization methods have
been used for gene expression microarray data, there may
be characteristics of miR expression that will influence the
optimal choice of normalization method for miR microar-
ray data. The number of probes on a miR microarray is
typically much smaller (a few hundred or less) than the
number of probes on a gene expression cDNA microarray
Table 4 Summary statistics for 9 different renal cancer
cell lines based on intra-class correlations (ICCs)
computed for replicate miR microarray data processed
using different normalization methods
Cell lines Min Max Median Mean SD
1 0.91 0.96 0.95 0.95 0.01
2 0.84 0.95 0.94 0.93 0.03
3 0.89 0.94 0.93 0.93 0.01
4 0.75 0.92 0.91 0.90 0.03
5 0.66 0.90 0.90 0.88 0.05
6 0.89 0.94 0.93 0.93 0.02
7 0.76 0.91 0.90 0.89 0.03
8 0.90 0.95 0.95 0.94 0.01
9 0.92 0.93 0.93 0.93 0.00
Table 3 Summary statistics for performance of different
normalization methods based on intra-class correlations
(ICCs) computed for replicate miR microarray data
obtained using 9 different renal cancer cell lines
Methods Min Max Median Mean SD
No.Norm 0.66 0.95 0.91 0.89 0.09
Mean 0.90 0.96 0.94 0.93 0.02
t.Mean 0.90 0.96 0.94 0.93 0.02
Median 0.90 0.96 0.94 0.93 0.02
Lowess 0.87 0.95 0.91 0.91 0.03
Quantile 0.88 0.94 0.92 0.91 0.02
Mean.10 0.90 0.95 0.93 0.93 0.02
Mean.20 0.90 0.96 0.93 0.93 0.02
Mean.30 0.90 0.96 0.94 0.93 0.02
t.Mean.10 0.90 0.95 0.93 0.93 0.02
t.Mean.20 0.90 0.96 0.93 0.93 0.02
t.Mean.30 0.90 0.96 0.94 0.93 0.02
Median.10 0.90 0.95 0.93 0.93 0.02
Median.20 0.90 0.95 0.93 0.93 0.02
Median.30 0.90 0.95 0.94 0.93 0.02
Lowess.10 0.75 0.92 0.89 0.86 0.06
Lowess.20 0.86 0.94 0.90 0.90 0.03
Lowess.30 0.87 0.95 0.90 0.91 0.03
Quantile.10 0.89 0.94 0.92 0.92 0.02
Quantile.20 0.89 0.95 0.93 0.92 0.02
Quantile.30 0.90 0.95 0.93 0.92 0.02
Quantile.40 0.89 0.95 0.93 0.92 0.02
Figure 2 D o tp l o tf o rc o m p a r i s o no fICCso b s e r v e df o r
different normalization methods applied to replicate miR
microarray data from 9 renal cancer cell lines. The y axis is the
intra-class correlation coefficient (ICC), and the x-axis lists different
normalization methods. The x-axis indicates the normalization
method used. The shorthand notation for the normalization method
is the name of the main approach (Median, Mean, trimmed Mean,
Lowess, or Quantile) with a suffix indicating the size of the invariant
set used, if any (.10,.20,.30,.40). No suffix indicates that the full set of
miRs was used.
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of differentially expressed miRs comparing across samples
in a miR microarray experiment might be higher than the
proportion of differentially expressed genes typically
expected for gene expression microarray studies. It may be
difficult to anticipate what percentage of miRs are likely to
be truly invariant across a set of samples used in an
experiment, so ad hoc decisions may have to be made for
the invariant set size to be used for normalization methods
that use invariant sets. Our results suggested that using an
invariant set consisting of only 10% of the miRs resulted in
diminished performance compared to methods using lar-
ger invariant sets, but the appropriate invariant set size
obviously could depend on the particular experimental
setting. Global mean and median methods require
assumptions that either the number of differentially
expressed miRs is not too large or that the amount of
over-expression and under-expression of miRs within each
sample is somehow balanced so that the mean or median
is still a reasonable indicator of overall shift in expression
level due to technical factors. Researchers still need to
consider carefully which assumptions underlying the dif-
ferent normalization methods appear most reasonable for
their experimental setting and possibly consider more
than one normalization approach to determine the sensi-
tivity of their results to normalization method used.
Additional material
Additional file 1: Table presenting p-values resulting from Wilcoxon
signed-rank tests used to compare ICCs of different normalization
methods applied to data obtained by miR microarray analysis of 10
lung cancer cell lines.
Additional file 2: Table presenting p-values resulting from Wilcoxon
signed-rank tests used to compare ICCs of different normalization
methods applied to data obtained by miR microarray analysis of 9
renal cancer cell lines.
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